For the first time, the FDA approves a CBD-containing drug

As I have written in previous posts, CBD, or cannabidiol, an active ingredient of marijuana, kills myeloma cells, so the news I came across early this morning is of huge interest to me.

In a nutshell, for the first time ever, the FDA has approved a CBD-containing oral solution (= a strawberry-flavored syrup) for the treatment of rare but severe forms of epilepsy in children.

Note: this syrup does not contain THC, the ingredient in marijuana that makes people “high.”

It may not come without side effects, such as sleepiness and increased liver enzymes (like most anti-seizure drugs, it appears), as you can read in the FDA press release:

Compared to seizures, however, the potential side effects seem tolerable. Here’s a Time magazine story about a 10-year-old girl with Dravet syndrome who participated in the CBD clinical trial in 2016, for example:

Anyway, I think this is very exciting…and promising…!!!